Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Treatment for Neonatal Opioid Withdrawal Syndrome

NCT05129020 is registered in ClinicalTrials.gov with Spark Biomedical, Inc. as lead sponsor.

NCT NCT05129020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05129020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Treatment for Neonatal Opioid Withdrawal Syndrome
Lead sponsor
Spark Biomedical, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 27, 2022
Completion date
January 31, 2027
Enrollment
52 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal abstinence syndrome, neonatal opioid withdrawal syndrome